Sage Therapeutics Announces Third Quarter 2022 Financial Results and Highlights Pipeline and Business Progress
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today reported business highlights and financial results for the…
Details